A randomized, double-blind, placebo-controlled, parallel-group 12-week pilot phase II trial of SaiLuoTong (SLT) for cognitive function in older adults with mild cognitive impairment.
Genevieve Zara SteinerAlan BensoussanElana R Andrews-MarneyMahmoud A Al-DabbasAdele E CaveChristine L ChiuKaterina ChristofidesFrances M De BlasioLauren S DewsburyNaomi L FaganJack S FogartyLena C HattomMark I HohenbergDeyyan JafarDiana KaramacoskaChai K LimJianxun LiuNajwa-Joelle MetriD Vincent OxenhamHolly RatajecNikita RoyDanielle G ShiptonDavid VarjabedianDennis H ChangPublished in: Alzheimer's & dementia (New York, N. Y.) (2023)
SaiLuoTong (SLT) improves delayed memory retrieval and executive function in people with mild cognitive impairment (MCI).SLT is well tolerated in people ≥ 60 years.The sample of community dwellers with MCI was well characterized and homogeneous.